JP2010538054A5 - - Google Patents

Download PDF

Info

Publication number
JP2010538054A5
JP2010538054A5 JP2010523589A JP2010523589A JP2010538054A5 JP 2010538054 A5 JP2010538054 A5 JP 2010538054A5 JP 2010523589 A JP2010523589 A JP 2010523589A JP 2010523589 A JP2010523589 A JP 2010523589A JP 2010538054 A5 JP2010538054 A5 JP 2010538054A5
Authority
JP
Japan
Prior art keywords
lipoteichoic acid
pharmaceutical composition
pneumothorax
combination
pleural effusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010523589A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010538054A (ja
JP5623906B2 (ja
Filing date
Publication date
Priority claimed from GBGB0717442.8A external-priority patent/GB0717442D0/en
Application filed filed Critical
Publication of JP2010538054A publication Critical patent/JP2010538054A/ja
Publication of JP2010538054A5 publication Critical patent/JP2010538054A5/ja
Application granted granted Critical
Publication of JP5623906B2 publication Critical patent/JP5623906B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010523589A 2007-09-07 2008-09-08 胸水貯留または気胸の処置において使用するためのリポテイコ酸を含む組成物 Expired - Fee Related JP5623906B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0717442.8A GB0717442D0 (en) 2007-09-07 2007-09-07 Compositions and uses thereof
GB0717442.8 2007-09-07
PCT/GB2008/003019 WO2009030929A1 (en) 2007-09-07 2008-09-08 Compositions comprising lipoteichoic acid for use in treating pleural effusion or pneumothorax

Publications (3)

Publication Number Publication Date
JP2010538054A JP2010538054A (ja) 2010-12-09
JP2010538054A5 true JP2010538054A5 (enExample) 2011-10-27
JP5623906B2 JP5623906B2 (ja) 2014-11-12

Family

ID=38640413

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010523589A Expired - Fee Related JP5623906B2 (ja) 2007-09-07 2008-09-08 胸水貯留または気胸の処置において使用するためのリポテイコ酸を含む組成物

Country Status (8)

Country Link
US (1) US8536139B2 (enExample)
EP (1) EP2194991B1 (enExample)
JP (1) JP5623906B2 (enExample)
CN (1) CN101801392B (enExample)
AT (1) ATE545424T1 (enExample)
ES (1) ES2382501T3 (enExample)
GB (1) GB0717442D0 (enExample)
WO (1) WO2009030929A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE8611854U1 (de) 1986-04-30 1986-06-19 Stahl Gmbh & Co Maschinenfabrik, 7140 Ludwigsburg Kombinierte Vierbruchfalzmaschine
EP2545909A1 (en) * 2011-07-12 2013-01-16 Lunamed AG Combination of D-Amino Acids and Lipoteichoic Acid
EP2589387A1 (en) 2011-11-04 2013-05-08 Lunamed AG Use of a teichoic acid for the treatment of malignant liquor cerebrospinalis in the brain
EP2589388A1 (en) 2011-11-04 2013-05-08 Lunamed AG Use of a Teichoic acid for the treatment of malignant ascites
CN103961512A (zh) * 2014-06-02 2014-08-06 王志红 一种用于创伤性气胸护理的中药制剂及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4714196A (en) * 1995-01-30 1996-08-21 Peter Truog Antitumor and anticholesterol preparations containing a lipoteichoic acid from steptococcus
WO2005030133A2 (en) 2003-09-22 2005-04-07 Yale University Treatment with agonists of toll-like receptors
WO2008048560A2 (en) 2006-10-16 2008-04-24 Yale University Toll-like receptor agonist regulation of vegf-induced tissue responses

Similar Documents

Publication Publication Date Title
JP2010222367A5 (enExample)
JP2015512418A5 (enExample)
BRPI0806392A8 (pt) uso de aclidínio, aclidínio, método de tratamento ou prevenção e composição farmacêutica
MX2021004546A (es) Composiciones de suministro de farmaco implantables y metodos de uso de las mismas.
EP3682875A3 (en) Methods of treating pediatric metabolic syndrome
BRPI0906181A2 (pt) "método para tratamento de uma disfunção hiperproliferativa, composição farmacêutica, uso de uma combinação terapêutica na fabricação de um medicamento para o tratamento de câncer, artigo de fabricação para tratamento de uma disfunção hiperproliferativa, método para determinação de compostos a serem usados em combinação para o tratamento de câncer e método para determinação de uma combinação terapêutica a ser usada para o tratamento de câncer"
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
CL2013001136A1 (es) Un agente inhibitorio de la fosfodiesterasa 7 (pde7) para ser usado en el tratamiento o la reduccion de la posibilidad de una adiccion; y composicion farmaceutica, forma de dosificacion unitaria y kit farmaceutico que incluyen al inhibidor de fosfodiesterasa 7 (pde7) y un agente terapeutico adicional.
HN2011001280A (es) Compuestos de arilo con sustituyentes heterociclicos y su uso
JP2014521735A5 (enExample)
HRP20220718T1 (hr) Kombinacijska terapija uključujući inhibitor mdm2 i jedan ili više dodatnih farmaceutski aktivnih sredstava za liječenje raka
NZ747657A (en) Treatment or prevention of cardiovascular events via the administration of a colchicine derivative
DE602007011913D1 (de) Pharmazeutische kombination mit 3- (3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol und paracetamol
AR091089A1 (es) Metodos de tratamiento que utilizan un compuesto de biguanida en una formulacion de liberacion demorada
HK1198869A1 (en) Combination treatments for hepatitis c
JP2013541583A5 (enExample)
WO2015038552A3 (en) Aspirin formulation for increased efficacy
MX2012000275A (es) Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal.
CL2014003503A1 (es) Composición farmacéutica para uso intramamario que comprende un ácido fosfónico y al menos un agente antimicrobiano; y uso para el tratamiento o prevención de mastitis en mamífero no humano.
JP2010538054A5 (enExample)
JP2015535291A5 (enExample)
WO2017182873A3 (en) Peptide-oligourea foldamer compounds and methods of their use
CL2012001940A1 (es) Composiciones que comprenden extractos de andrographis paniculata combinados con extractos de ginkgo biloba complejados con fosfolípidos; y su uso en la preparación de un medicamento para el tratamiento de alzheimer y esclerosis múltiple.
JP2007119497A5 (enExample)
JP2013520447A5 (enExample)